Travere Therapeutics, Inc. TVTX Intangible Purchases
Intangible Purchases at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s intangible purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s intangible purchases?
- Travere Therapeutics, Inc. (TVTX) reported intangible purchases of $22.18M in Q1 2026.
- How has Travere Therapeutics, Inc.'s intangible purchases changed year-over-year?
- Travere Therapeutics, Inc.'s intangible purchases increased by 88.2% year-over-year, from $11.78M to $22.18M.
- What is the long-term trend for Travere Therapeutics, Inc.'s intangible purchases?
- Over 4 years (2021 to 2025), Travere Therapeutics, Inc.'s intangible purchases has grown at a 32.2% compound annual growth rate (CAGR), from $19.05M to $58.16M.
- What does intangible purchases mean?
- Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.